3,4-Di -isobutyryloxy-N-3-(4-isobutyryloxyphenyl)-1-methyl-n-propyl!-beta-phene thylamine cyclodextrin complexes
US4424209A · kind A · utility
14Cited by
2References
4Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jun 21, 1982 |
| Grant date | Jan 3, 1984 |
| Priority date | — |
| Expiry date | Jun 21, 2002 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC08B37/0015
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Cardiac contractility agents are provided which are 3,4-di-isobutyryloxy-N-3-(4-isobutyryloxyphenyl)-1-methyl-n-propyl!-beta- phenethylamine, preferably orally deliverable forms which are cyclodextrin complexes.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.